Nuvation Bio Closes Transaction with Panacea, Debuts as Publicly Traded Oncology Company
Combined company renamed Nuvation Bio Inc., will be listed on the New York Stock Exchange under ticker symbol "NUVB" Strong cash position...
Nuvation Bio Closes Transaction with Panacea, Debuts as Publicly Traded Oncology Company
Sana snags $587.5M IPO to catapult cell therapies into the clinic
Gilead Sciences and Gritstone Announce Collaboration For HIV Cure
Gritstone Advances Second Generation COVID-19 Vaccine “CORAL” Program with Support from NIAID
Tessera Therapeutics Attracts Over $230M in Series B Financing to Advance ‘Gene Writing’
Top Life Sciences Startups to Watch in 2021
Beam Therapeutics Presents Updated Data from Novel Base Editing Programs for Sickle Cell Disease
Gritstone Oncology Advances into Phase 2 Expansion Cohorts for its Personalized Neoantigen Therapy
eFFECTOR’s Zotatifin (eFT226) Downregulates Key Oncogenic Driver Proteins Including RTKs